cerca CERCA
Lunedì 17 Gennaio 2022
Aggiornato: 18:21
Temi caldi

World vaccine Congress Europe

comunicato stampa

Novavax to Participate in World Vaccine Congress Europe

GAITHERSBURG, Md., Oct. 15, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Vivek Shinde, M.D., Vice President, Clinical Development, will deliver a presentation during the World Vaccine Congress Europe 2021. A topic of discussion will be Novavax' COVID-NanoFlu™ Combination Vaccine, which combines the company's recombinant nanoparticle protein-based...

ora in
Prima pagina
articoli
in Evidenza